|
Abstract: Systolic anterior motion of the mitral valve and mitral-septal
contact is the usual cause of dynamic left ventricular outflow obstruction
in hypertrophic cardiomyopathy. That true obstruction actually occurs
is now established based on cardiac catherization and echocardiographic
evidence. A mid-systolic drop in left ventricular systolic ejection
velocity due to obstruction has recently been demonstrated. Echocardiographic
data indicates that systolic anterior motion of the mitral valve
is initiated by flow drag; the mitral valve is swept toward the
septum by the pushing force of flow. After mitral-septal contact,
obstruction begets further obstruction as the pressure gradient
pushes the mitral valve into the septum. Most symptomatic patients
can be treated successfully with negative inotropic drugs. These
medications reduce systolic anterior motion and obstruction by decreasing
early left ventricular ejection acceleration, decreasing the early
systolic pushing force on the protruding mitral leaflet. Patients
who do not improve on medication, generally benefit from surgery.
Newer interventions to relieve obstruction, dual chamber pacing
and percutaneous transluminal septal myocardial ablation (PTSMA)
are under active investigation.
Hypertrophic cardiomyopathy (HCM) is a condition characterized
by thickening of the myocardium without apparent clinical cause.
Dynamic obstruction occurs in approximately 25% of HCM patients.
Obstruction to left ventricular outflow most often occurs due to
systolic anterior motion of the mitral valve and mitral-septal contact.
Less commonly an anomalous papillary muscle inserts into the outflow
tract causing obstruction (1). Also uncommonly, mid-ventricular
obstruction due to systolic apposition of the mid-cavity left ventricular
walls can occur (2, 3). This paper will first concentrate on the
common form of outflow tract obstruction caused by systolic anterior
motion and mitral-septal contact.
In the 1970s and 1980s there was considerable debate in the scientific
literature as to whether outflow tract obstruction actually occurs
in HCM. This debate has now been settled in favor of the presence
of obstruction by several observations.
First, in patients with obstructive HCM, a significant pressure
gradient is found in the catheterization laboratory between catheters
situated in the aorta and inflow tract of the left ventricle near
the mitral valve (4). This observation resolves the question as
to whether the observed pressure difference might be due to catheter
entrapment in the left ventricle. Catheter entrapment does not occur
in the inflow portion of the left ventricle, near the mitral valve.
Second, left ventricular ejection time is prolonged in HCM only
when obstruction is present (5). Third, Doppler studies show acceleration
of flow velocity at the point of mitral-septal contact in the outflow
tract. A gradient can be measured with Doppler across the narrowing
(6). Fourth, ejection flow velocity falls in mid-systole both in
the aorta and in the left ventricle due to obstruction (7, 8).
|
Figure 1
Upper panel:
Pulsed Doppler echocardiogram recorded in the left ventricle 2.5 cm apical of the mitral valve and 1 cm from the septum. Mid-systolic drop in left ventricular systolic ejection velocity is seen, after the arrow.
Lower panel:
Continuous wave Doppler through the left ventricular outflow tract jet in the same patient. The close temporal relationship between the nadir of the mid-systolic drop in the left ventricle and the peak velocity of the jet is displayed. This close temporal relationship links the cause of the mid-systolic drop to obstruction.
Reprinted from Sherrid et al (8) by permission from the Journal of the American Society of Echocardiography 1997;10:707-12 © 1997 Mosby-Year Book Inc.
|
Recently a mid-systolic drop in left ventricular velocity has been
observed in the left ventricular cavity itself (8). This unusual
flow contour has been termed the lobster claw abnormality, because
of its characteristic appearance, shown in figure 1. Such abnormalities
are only seen when the measured outflow pressure gradient is greater
than about 60 mm Hg. We have not observed this pattern in the left
ventricle in non-obstructed HCM. Also, when patients are successfully
treated, and outflow obstruction is abolished, the mid-systolic
drop is no longer seen. It appears that the mid-systolic drop is
due to obstruction; the heart "stutters" in mid-systole due to the
sudden imposition of afterload. This abnormality highlights the
effect of obstruction on the left ventricle.
Patients with obstructive HCM present with symptoms of dyspnea,
angina and syncope. The pathophysiology of symptoms in HCM is complex
and multifactorial; symptoms develop for a variety of other reasons
besides obstruction. These other factors operate in non-obstructed
HCM patients and include the hypertrophy itself, diastolic dysfunction,
increased diastolic pressure, impaired coronary flow reserve and
non-atherosclerotic occlusive disease of the intramural coronary
arterioles (9, 10).
However, obstruction in addition to these other abnormalities may
cause enough symptoms to bring the patient to medical attention.
Obstruction, increases systolic left ventricular pressure, systolic
wall tension and myocardial work. Coronary perfusion pressure is
decreased as aortic diastolic pressure falls and left ventricular
diastolic pressure rises. Pacing produced ischemia and anaerobic
metabolism is documented (11, 12). Moreover, abnormalities in myocardial
metabolism and blood flow are reversed after successful myectomy.
(13) In addition, systolic anterior motion causes mitral regurgitation;
the functional deformation of the mitral valve causes incomplete
coaptation.
Syncope and pre-syncope may be caused by arrhythmias but also may
be a manifestation of obstruction. Patients will often note pre-syncope
after exertion; gradients have been shown to increase after completion
of exercise.
NEXT PAGE
|